Enoda
About Enoda
Enoda utilizes high-throughput screening and systems immunology to engineer cell therapies that enhance the therapeutic potential of cells by mapping underexplored biological pathways. The company addresses the limitations of traditional cell therapy development, which often focuses narrowly on known receptors and cell types, by creating optimized cell phenotypes for a broader range of diseases.
```xml <problem> Traditional cell therapy development often focuses on well-known receptors and cell types, potentially overlooking other biological pathways that could enhance therapeutic efficacy. This narrow focus can limit the potential of cell therapies to address a broader range of diseases. </problem> <solution> Enoda employs high-throughput screening and systems immunology to engineer cell therapies by mapping underexplored biological pathways. The company aims to create optimized cell phenotypes for a wider range of diseases by using molecular tools to rapidly and unbiasedly map how these pathways improve the therapeutic function of cells. Enoda combines its molecular tooling platform with high-throughput screening and systems immunology to engineer the right cell type with the right tools for the right indication. The company's goal is to precisely engineer every facet of the cell to maximize its therapeutic potential. </solution> <features> - Molecular tooling platform for mapping underexplored pathways - High-throughput screening to identify optimal cell phenotypes - Systems immunology to engineer the right cell type </features> <target_audience> Enoda's primary audience includes researchers and pharmaceutical companies involved in cell therapy development, seeking to enhance the therapeutic potential of cells for various diseases. </target_audience> ```
What does Enoda do?
Enoda utilizes high-throughput screening and systems immunology to engineer cell therapies that enhance the therapeutic potential of cells by mapping underexplored biological pathways. The company addresses the limitations of traditional cell therapy development, which often focuses narrowly on known receptors and cell types, by creating optimized cell phenotypes for a broader range of diseases.
Where is Enoda located?
Enoda is based in Stanford, United States.
When was Enoda founded?
Enoda was founded in 2023.
- Location
- Stanford, United States
- Founded
- 2023
- Employees
- 6 employees